share_log

SINO BIOPHARM: NOTIFICATION OF BOARD MEETING

HKEX ·  Aug 1, 2025 16:40

Summary by Futu AI

中國生物製藥宣佈,將於2025年8月18日(星期一)召開董事會會議,主要議程包括審議及批准截至2025年6月30日止六個月期間之未經審核中期業績,同時將考慮派發中期股息事宜。公司董事會現由六位執行董事及五位獨立非執行董事組成,執行董事包括謝其潤女士、謝炳先生、鄭翔玲女士、謝承潤先生、謝炘先生及田舟山先生;獨立非執行董事包括陸正飛先生、李大魁先生、魯紅女士、張魯夫先生及李國棟醫生。
中國生物製藥宣佈,將於2025年8月18日(星期一)召開董事會會議,主要議程包括審議及批准截至2025年6月30日止六個月期間之未經審核中期業績,同時將考慮派發中期股息事宜。公司董事會現由六位執行董事及五位獨立非執行董事組成,執行董事包括謝其潤女士、謝炳先生、鄭翔玲女士、謝承潤先生、謝炘先生及田舟山先生;獨立非執行董事包括陸正飛先生、李大魁先生、魯紅女士、張魯夫先生及李國棟醫生。
SINO BIOPHARM announces that it will hold a Board of Directors meeting on Monday, August 18, 2025. The main agenda items include the review and approval of the unaudited interim results for the six-month period ending June 30, 2025, and the consideration of the declaration of an interim dividend.The company's Board of Directors currently consists of six executive directors and five independent non-executive directors. The executive directors are Ms. Xie Qiran, Mr. Xie Bing, Ms. Zheng Xiangling, Mr. Xie Chengrun, Mr. Xie Xin, and Mr. Tian Zhoushan; the independent non-executive directors are Mr. Lu Zhengfei, Mr. Li Daikui, Ms. Lu Hong, Mr. Zhang Lufu, and Dr. Li Guodong.
SINO BIOPHARM announces that it will hold a Board of Directors meeting on Monday, August 18, 2025. The main agenda items include the review and approval of the unaudited interim results for the six-month period ending June 30, 2025, and the consideration of the declaration of an interim dividend.The company's Board of Directors currently consists of six executive directors and five independent non-executive directors. The executive directors are Ms. Xie Qiran, Mr. Xie Bing, Ms. Zheng Xiangling, Mr. Xie Chengrun, Mr. Xie Xin, and Mr. Tian Zhoushan; the independent non-executive directors are Mr. Lu Zhengfei, Mr. Li Daikui, Ms. Lu Hong, Mr. Zhang Lufu, and Dr. Li Guodong.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.